NovoCure Ltd·4

Mar 5, 4:32 PM ET

Ben Arye Barak 4

4 · NovoCure Ltd · Filed Mar 5, 2026

Insider Transaction Report

Form 4
Period: 2026-03-03
Ben Arye Barak
General Counsel
Transactions
  • Award

    Ordinary Shares

    [F1]
    2026-03-03+50,125242,453 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-03-03+73,34073,340 total
    Exercise: $13.30Exp: 2036-03-03Ordinary Shares (73,340 underlying)
Footnotes (2)
  • [F1]Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.
  • [F2]Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.
Signature
Steven Robbins, as attorney in fact for Ben Arye, Barak|2026-03-05

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT